Back to Search Start Over

Cognition Therapeutics announces results from the SEQUEL study of CT1812

Source :
The Fly. August 22, 2024
Publication Year :
2024

Abstract

Cognition Therapeutics announced that results from the SEQUEL study of CT1812, the Company's lead candidate for the treatment of Alzheimer's disease, were published in The Journal of Prevention of Alzheimer's [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
The Fly
Publication Type :
Periodical
Accession number :
edsgcl.805740609